Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Universities
Accelerators
Workspaces
Service providers
More organizations
Matching tool
Investment heatmap
Themes
Reports
Companies
ViaCyte
Team
Team
Save
ViaCyte
First in Kind Cellular Treatment for Diabetes.
Learn more
Launch date
1999
Employees
51-200 people
Market cap
-
Enterprise valuation
AUD495m
(Public information from Jul 2022)
San Diego California (HQ)
http://viacyte.com
https://twitter.com/viacyte
https://www.facebook.com/viacyte
https://www.linkedin.com/company/viacyte-formerly-novocell-
B2B
manufacturing
health
biotechnology
pharmaceutical
hard tech
biotechnology
horizon europe
biotech and pharma
risk management
diabetes
personal health
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Patents (122)
Authorizing premium user...